Human governed
AI proposes and organizes. Scientific experts decide.
AI-native therapeutic design
A new computational foundation for therapeutic possibility.
Silicura AI is building a human-governed, GPU-accelerated agentic AI platform for drug development - helping scientific teams explore, prioritize, and advance therapeutic programs with traceable evidence and expert control.
Research-stage platform · Three provisional applications filed · New Jersey, USA
PROGRAM NAVIGATOR ACTIVE R&D
01 / 04
Define what must be learned
Frame a therapeutic research objective with explicit context, boundaries, and decision criteria.
Illustrative platform concept · not a clinical or validated result
03U.S. provisional patent applications filed
MDPhysician-led scientific AI company
GPUBuilt for accelerated research computing
The flagship platform · confidential build
Therapeutic design needs more than another prediction.
The central challenge is not producing more computational outputs. It is deciding which possibilities deserve scarce scientific time, experimental capacity, and capital.
Silicura is creating a unified research environment where AI supports exploration while qualified experts retain authority over every material decision.
SIL / DRUG BUILDER / 01
Drug Builder
Agentic AI for computational therapeutic design
A private research environment for moving from complex biological questions toward focused, reviewable therapeutic programs - while preserving the evidence, context, and uncertainty behind each decision.
In active developmentEvidence aware
Research context remains connected to the decisions it informs.
Uncertainty explicit
Limitations remain visible instead of being hidden behind a score.
Traceable by design
Outputs are structured for review, challenge, and reproducibility.
Development status / Private
A confidential agentic AI workspace for drug development.
Designed to move from a defined therapeutic objective to structured, reviewable design decisions while keeping evidence, uncertainty, and expert authority visible.
Public descriptions are intentionally bounded. Patent-sensitive methods, system architecture, and program data remain confidential.
Request a private briefingSelected platform directions
Extending accountable intelligence across the therapeutic lifecycle.
Public concept overviews communicate the intended application areas without disclosing proprietary implementation.
010203
Digital Wet Lab AI
A research environment for organizing multimodal biological questions, computational experiments, and scientific learning.
Clinical Development AI
A public concept for human-governed protocol intelligence, trial exploration, and traceable development decisions.
Medical Affairs AI
A public concept for evidence intelligence, scientific exchange, field readiness, and accountable medical workflows.
Why Silicura
“In science, an answer that cannot be examined is not yet a decision.”
Silicura is being built at the intersection of medicine, computational science, and accountable AI—with the ambition to make therapeutic design more focused, interpretable, and scientifically defensible.
Founder
Saeed Arasteh, MD
Physician · AI scientist · systems builder
Silicura is being built as a multidisciplinary scientific company - bringing medicine, computational research, and accountable AI together around better therapeutic decisions.
Research partnerships · Scientific collaboration · Investment
Let’s explore what therapeutic design can become.
Silicura welcomes conversations with life-science leaders, research partners, technical collaborators, and investors who share a commitment to rigorous and accountable scientific AI.
info@silicura.ai Business correspondence971 US Highway 202N, Suite NBranchburg, NJ 08876 · USA